THIS IS NOT A REQUEST FOR PROPOSALS OR A REQUEST FOR QUOTATIONS; IT IS STRICTLY A REQUEST FOR INFORMATION (RFI). NEITHER UNSOLICITED PROPOSALS NOR ANY OTHER KINDS OF OFFERS WILL BE CONSIDERED IN RESPONSE TO THIS RFI. NO CONTRACT WILL BE AWARDED PUR SUANT TO THIS ANNOUNCEMENT. 1.0 SUBJECT: The Air Force Medical Evaluation Support Activity (AFMESA) is conducting market research on physiologic monitoring systems (central station function, patient (inter/intrahospital) transport monitor, ambulatory telemetry). Systems may be com mercially available or likely to come to market within the next 12 to 18 months. Responses are due to this RFI by 4:00 PM on September 21, 2006. See section 6.0 for further information. 2.0 DISCLAIMER: This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are no t offers and will not be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. All information received in response to this RFI that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future RFP, as well as those regarding the nature of the services to be performed under the physiologic monitoring initiative will not be entertained. 3.0 DESCRIPTION: Monitoring systems must be FDA approved at time of purchase. The system must be light-weight, self-contained, rapidly deployable, and capable of monitoring multiple patients. The individual patient monitors must wirelessly transmit data t o a central monitoring function. 4.0 REQUIREMENTS: Prospective systems should supply the following capabilities: self-contained in ruggedized transport case; capability of monitoring a combination of up to 12 bedside and telemetry patients from a bi-directional communication central locat ion with transceiver and ST/arrhythmia analysis; patient monitors must be capable of independent data display as a stand-alone device or allow transmission of patient data through a telemetry system. System must have capability to continuously monitor pat ients including neonatal to geriatric. Monitoring system must be capable of using 120-240VAC electrical power as well a capability to operate for up to 8 hours on internal batteries. The monitoring system must provide all vital sign parameters offered in standard emergency room and critical care units (i.e., easy-to-read ECG waveforms, heart rate, SpO2, alarm, alert, arrhythmia, vital sign information). The monitoring systems should in corporate arrhythmia and system fault detection along with full disclosure (upwards to 96 hours). Systems must be usable in a variety of military medical treatment environments and various evacuation platforms (air, land, sea). The system must be ruggedized, vibration-resistant, and be capable of operation in a wide range of environmental conditions. Systems must be capable of rapid installation, set-up and presentation of patient data in an easy to understand format and able to transmit the parameter information wirelessly to its central monitoring function. The physiologic monitoring system must be easily portable (two-person carry) when packed for storage (in harden case). The Government encourages creativity and innovation in responses to this RFI. The purpose of this RFI is to gather information about commercially available products that meet the requirements enumerated above. 5.0 CONTACT INFORMATION: The Point of Contact for this RFI is Maj. Thomas Walker, (301) 619-8600,
[email protected].